首页> 外文OA文献 >Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (BATS)

【2h】

Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (BATS)

机译：五名晚期胰腺癌患者在抗CD3 x抗EGFR双特异性抗体武装的活化T细胞（BATS）的I期研究中

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 抗人卵巢癌/抗人CD3单链双特异性抗体的生物学活性研究 [J] . 杨介钻, 张众, 马骊, 癌症（英文版） . 2005,第007期
2. Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (BATS) [J] . Lawrence G Lum, Minsig Choi, Archana Thakur, Journal for ImmunoTherapy of Cancer . 2015,第S2期

机译：五名晚期胰腺癌患者在抗CD3 x抗EGFR双特异性抗体武装的活化T细胞（BATS）的I期研究中
3. Clinical and immune responses to anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (EGFR BATs) in pancreatic cancer patients [J] . Lum, L.G., Thakur, Oncoimmunology. . 2020,第1期

机译：抗CD3 X抗EGFR双特异性抗体武装活化T细胞（EGFR蝙蝠）在胰腺癌患者中的临床和免疫应答
4. Vaccination with bispecific antibody armed T cells (BATC) in metastatic breast cancer patients and transfer of anti-breast cancer immunity in primed T cells after stem cell transplant: a proof of principle study [J] . Archana Thakur, Lawrence G Lum, Vidya Kondadasule, Journal for ImmunoTherapy of Cancer . 2015,第S2期

机译：在转移性乳腺癌患者中用双特异性抗体武装T细胞（BATC）进行疫苗接种以及干细胞移植后初免T细胞中抗乳腺癌免疫力的转移：原理研究的证明
5. Improved T Cell Activation Bioassays to Advance the Development of Bispecific Antibodies and Engineered T Cell Immunotherapies [C] . Gopal Krishnan, Pete Stecha, Denise Garvin, Protein Engineering Summit. . 2018

机译：改进的T细胞活化生物测定促进双特异性抗体和工程化T细胞免疫检查的发育
6. CD16xCD33 bispecific killer cell engager (BiKE) activates natural killer (NK) cells from myelodysplastic syndrome (MDS) patients against primary MDS and myeloidderived suppressor cell (MDSC) CD33-positive targets. [D] . Gleason, Michelle K. 2014

机译：CD16xCD33双特异性杀伤细胞接合剂（BiKE）激活来自骨髓增生异常综合征（MDS）患者的自然杀伤（NK）细胞，以抵抗原发性MDS和髓样抑制细胞（MDSC）CD33阳性靶标。
7. Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (BATS) [O] . Lawrence G Lum, Minsig Choi, Archana Thakur, 2015

机译：五名晚期胰腺癌患者在抗CD3 x抗EGFR双特异性抗体武装的活化T细胞（BATS）的I期研究中
8. Phase II clinical trial using anti-CD3 × anti-HER2 bispecific antibody armed activated T cells (HER2 BATs) consolidation therapy for HER2 negative (0–2+) metastatic breast cancer [O] . Lawrence G. Lum, Zaid Al-Kadhimi, Abhinav Deol, 2021

机译：二期临床试验使用抗CD3×抗HER2双特异性抗体武装活化T细胞（HER2蝙蝠）固结治疗HER2阴性（0-2 +）转移性乳腺癌
9. Cell Penetrating Bispecific Antibodies for Targeting Oncogenic Transcription Factors in Advanced Prostate Cancer. [R] . Lilly, M., Weisbart, R. 2016

机译：细胞穿透双特异性抗体靶向晚期前列腺癌的致癌转录因子。

Five advanced pancreatic cancer patients in a Phase I study of anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (BATS)

著录项

引文网络

相似文献

相关主题

期刊订阅